Prostatis Group’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,336
Closed -$1.03M 168
2025
Q3
$1.03M Buy
4,336
+695
+19% +$175K 0.26% 76
2025
Q2
$993K Sell
3,641
-796
-18% -$213K 0.28% 72
2025
Q1
$1.19M Buy
4,437
+292
+7% +$90.8K 0.38% 59
2024
Q4
$1.39M Sell
4,145
-20
-0.5% -$6.38K 0.4% 60
2024
Q3
$1.14M Buy
4,165
+340
+9% +$87.1K 0.37% 63
2024
Q2
$1M Buy
+3,825
New +$1.02M 0.35% 65
2023
Q3
Sell
-12,901
Closed -$15.8K 130
2023
Q2
$15.8K Buy
+12,901
New +$2.63M 0.01% 238

Other funds holding CRM

Prostatis Group's CRM Position: Q4 2025 in Review

Prostatis Group sold out of Salesforce (CRM) in Q4 2025, closing a stake of 4,336 shares — an estimated $1.03M sold.

Prostatis Group first reported a position in CRM in Q2 2023 and held it in 7 quarters. The position peaked at $1.39M in Q4 2024. 2,948 funds tracked by Wall St. Rank hold CRM as of Q4 2025.

  • Prostatis Group reported no remaining Salesforce position as of Q4 2025 after selling out during the quarter.
  • Prostatis Group sold 4,336 Salesforce shares in Q4 2025, an estimated $1.03M.
  • Prostatis Group first reported a position in Salesforce in Q2 2023 and held it in 7 quarters.
  • Prostatis Group's Salesforce position peaked at $1.39M in Q4 2024.
  • 2,948 funds tracked by Wall St. Rank held Salesforce as of Q4 2025.

Based on Prostatis Group's 13F filing for Q4 2025, filed 17 Feb 2026.